Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Granisetron Hydrochloride bulk supplier for pharma manufacturers

Granisetron Hydrochloride Suppliers & Bulk Manufacturers

Available Forms: Injection (IV/SC), Oral Tablet

Available Strengths: Injection: 1 mg/mL, 3 mg/3 mL; Oral Tablet : 1 mg

Reference Brands: Kytril® (US & EU)

Category: Oncology Cancer Care

Granisetron Hydrochloride is an FDA- and EMA-approved antiemetic used in oncology to prevent chemotherapy- and radiation-induced nausea and vomiting. It is widely used in hospitals and cancer centers. B2B buyers in the US and EU can source Granisetron from certified pharmaceutical wholesalers with GMP compliance and reliable supply.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Granisetron Hydrochloride is a trusted antiemetic used in oncology to prevent nausea and vomiting caused by chemotherapy and radiation. Available in 1 mg tablets, 1 mg/mL injections, and transdermal patches (Sancuso®), it plays a critical role in supportive cancer care. Approved by the FDA and EMA, Granisetron is supplied by certified pharmaceutical wholesalers across the US and EU. Hospitals, oncology centers, and infusion clinics rely on this 5-HT3 antagonist for effective patient management. B2B buyers can source Granisetron in bulk with GMP-compliant quality, competitive pricing, and reliable delivery through licensed pharma distributors.

Granisetron Hydrochloride — third party manufacturing & bulk supply

Granisetron Hydrochloride is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Granisetron Hydrochloride is supplied as Injection (IV/SC), Oral Tablet — supplied in more than one dosage form, each with its own manufacturing economics, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Granisetron Hydrochloride listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Granisetron Hydrochloride →
Back to Listing

Frequently Asked Questions

Granisetron Hydrochloride is listed as Injection (IV/SC), Oral Tablet in Injection: 1 mg/mL, 3 mg/3 mL; Oral Tablet : 1 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Granisetron Hydrochloride is referenced against Kytril® (US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Gemcitabine

Strength:
200 mg, 1000 mg, 1500 mg

Form: Lyophilized powder for solution for injection/infusion

Reference Brands: Gemzar® (US & EU)

View Details
Imatinib Mesylate

Strength:
50 mg, 100 mg, 400 mg

Form: Tablet / Capsule

Reference Brands: Gleevec (EU & US), Veenat (India)

View Details
Irinotecan

Strength:
100 mg/5 mL, 300 mg/15 mL

Form: Injection/Infusion Solution

Reference Brands: Camptosar® (US & EU)

View Details
Fulvestrant

Strength:
250 mg/5 mL

Form: Injection

Reference Brands: Faslodex (EU & US),Fulzos (India)

View Details
Rasburicase

Strength:
1.5 mg/1.5 mL (1.5 mg vial)

Form: Injection

Reference Brands: Elitek® (US & EU)

View Details
Trastuzumab

Strength:
IV : 150 mg/ 7.5 mL (vial); SQ: 600 mg/ 5 mL (syringe)

Form: IV & SQ Injection

Reference Brands: Herceptin® (EU & US); Herceptin Hylecta® (subcutaneous formulation)

View Details
Ziv-Aflibercept

Strength:
25mg/ml

Form: Intravenous (IV)

Reference Brands: Zaltrap® (US & EU)

View Details
Nivolumab

Strength:
40 mg/4 mL (vial); 100 mg/10 mL (vial)

Form: Intravenous (IV)

Reference Brands: Opdivo® (EU & US)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.